Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction
Amber Capone had become afraid of her husband. The “laid-back, bigger than life and cooler than cool” man she’d married had become isolated, disconnected and despondent during his 13 years as a U.S. Navy SEAL. Typically, he was gone 300 days of the year, but when he was home, Amber and their two children walked on eggshells around him. “Everyone was just playing nice until he left again,” Amber says. In 2013, Marcus retired from the military. But life as a civilian only made his depression, anger, headaches, anxiety, alcoholism, impulsivity and violent dreams worse. Sometimes he’d get up...
Source: TIME: Health - April 5, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Drugs feature Magazine Mental Health Source Type: news

Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart disease who are taking the seizure and mental health medicine lamotrigine (Lamictal). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ultrasound spots cardiac arrhythmic sites better than ECG
Ultrasound can more accurately map arrhythmic sites in the heart for improve...Read more on AuntMinnie.comRelated Reading: ASTRO: Radiation therapy can calm rapid heart rhythm 3D models advance therapy for heart rhythm disorders SPECT, MRI together advance arrhythmia treatment 3D virtual heart helps pinpoint irregular heartbeat CTA plus stress tests help predict heart attacks (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2021 Category: Radiology Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Massive suicidal ingestion of caffeine: a case report with investigation of the cardiovascular effect/concentration relationships - Gr émain V, Chevillard L, Saussereau E, Schnell G, Megarbane B.
BACKGROUND: Caffeine poisoning may cause life-threatening arrhythmias and hemodynamic failure. We aimed to investigate the toxicokinetics (TK), toxicodynamics (TD) and TK/TD relationships of caffeine in a case of poisoning. CASE REPORT: A 47-year-old male ... (Source: SafetyLit)
Source: SafetyLit - March 17, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

The Year in Cardiovascular Medicine 2020: Arrhythmias The Year in Cardiovascular Medicine 2020: Arrhythmias
This paper reviews new guidelines and important clinical trials and studies that were published in 2020 in the field of arrhythmias and pacing.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

What Are Generalized Anxiety Disorder Treatment Components?
Discussion Generalized anxiety disorder (GAD) is “…excessive anxiety and worry about a number of events and activities coupled with at least one physical symptom, which may include fatigue, poor concentration, restlessness, irritability, muscle tension, and sleep difficulties.” Other ways it presents to the primary care office may be abdominal pain, headache or heart palpitations, dizziness, syncope, numbness, trembling, paresthesia, memory loss, or urinary frequency. It has an estimated prevalence of 15% and is the second most common anxiety disorder in children after social anxiety disorder. GAD can co...
Source: PediatricEducation.org - March 15, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

New-onset Arrhythmias Low in COVID-19 and Flu New-onset Arrhythmias Low in COVID-19 and Flu
New-onset atrial fibrillation or flutter is uncommon in patients hospitalized with COVID-19 and occurs at a rate similar to that seen in patients hospitalized with influenza.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 5, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

New open-source platform accelerates research into the treatment of heart arrhythmia's
(King's College London) An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering& Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterised by an irregular (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 26, 2021 Category: International Medicine & Public Health Source Type: news

RhythMedix Launches Next-Generation RhythmStar(R) Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity
Innovative RhythmStar® technology designed to improve cardiac monitoring for faster arrhythmia detection MOUNT LAUREL, N.J., Feb. 18, 2021 -- (Healthcare Sales & Marketing Network) -- RhythMedix, a leader in remote cardiac monitoring, today announc... Devices, Cardiology, Monitoring, Product Launch RhythMedix, RhythmStar, cardiac telemetry monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 18, 2021 Category: Pharmaceuticals Source Type: news

Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA® and ZYTIGA® plus prednisone (combination arm) or placebo a...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said C...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Hillrom buying cardiac patch maker Bardy Diagnostics for $375M
Bardy's CAM patch wearable  can remotely monitor patients’ cardiac activity or detect arrhythmia over a seven-day period. (Source: mobihealthnews)
Source: mobihealthnews - January 25, 2021 Category: Information Technology Source Type: news

Atrial fibrillation following low voltage electrical injury - Ghosh S, Chandra A, Sen S, Dutta S.
Electrical injuries can have myriad presentations, including significant cardiac involvement. Arrhythmias are the most frequently experienced cardiac affliction, of which sinus tachycardia or bradycardia, ventricular fibrillation, atrial or ventricular pre... (Source: SafetyLit)
Source: SafetyLit - January 25, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

What Causes Lethargy?
Discussion Lethargy is a common word used to describe a person who is drowsy, sluggish, listless and apathetic. Concentration may be difficult and they may have problems doing simple tasks. Many people actual mean fatigue or lassitude or being more tired when they use the word. In medical terms, lethargy is usually used to describe patients who have some type of excessive tiredness and usually have mental status changes with decreased alertness or arousal. Patients and health care providers both usually qualify the term and give more description to better communicate what is implied when using the term. This is true of man...
Source: PediatricEducation.org - January 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Paternal antisociality and growth in child delinquent behaviors: moderating effects of child sex and respiratory sinus arrhythmia - Julia Yan J, Schoppe-Sullivan SJ, Beauchaine TP.
In this study, we test parasympathetic nervous system (PNS) function as a vulnerability/se... (Source: SafetyLit)
Source: SafetyLit - January 1, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Breathing rate predicts therapeutic benefits for heart patients
(Technical University of Munich (TUM)) Conditions causing arrhythmia are among the most common cardiac conditions. A study headed by Prof. Georg Schmidt of the Technical University of Munich (TUM) has demonstrated for the first time that the nocturnal respiratory rate can help with an important prediction: It is an indicator of whether a defibrillator will help to extend the life of patients with arrhythmia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2020 Category: International Medicine & Public Health Source Type: news

Arrhythmias (Heart Rhythm Disorders)
Title: Arrhythmias (Heart Rhythm Disorders)Category: Diseases and ConditionsCreated: 10/15/2007 12:00:00 AMLast Editorial Review: 12/11/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - December 11, 2020 Category: Cardiology Source Type: news

New Data Demonstrate Long-Term Benefit of IMBRUVICA ® (ibrutinib) as First-Line Treatment for High-Risk Chronic Lymphocytic Leukemia
This study highlighted the need for cytogenetic/molecular testing before CIT treatment, consistent with clinical treatment guidelines.[8],[9]Real-World Prognostic Biomarker Testing, Treatment Patterns, And Dosing Among Patients With CLL/SLL From the informCLL™ Prospective Observational Registry (Abstract #547)An oral presentation on Monday, December 7, will feature results from the informCLL™ real-world prospective observational registry assessing treatment patterns in the era of novel agents.4 Key Study Findings:· The most common index treatment was IMBRUVICA®; the majority of patients treated with ...
Source: Johnson and Johnson - December 6, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Disease-Free Survival Data from CAPTIVATE Study Demonstrate Benefit of IMBRUVICA ® (ibrutinib)-Based Regimen as Fixed Duration, First-Line Treatment for Patients with Chronic Lymphocytic Leukemia
December 5, 2020 (RARITAN, N.J.) – New data from the Phase 2 CAPTIVATE study were presented today during an oral session at the 2020 American Society of Hematology (ASH) Annual Meeting (Abstract #123). The study evaluated the efficacy and safety of IMBRUVICA® (ibrutinib) plus venetoclax in the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and showed that, after achieving undetectable minimal residual disease (uMRD) in both the blood and bone marrow with the IMBRUVICA® combination regimen, the one-year disease-free survival (DFS) of patients randomized ...
Source: Johnson and Johnson - December 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Some COVID Patients Struggling With Lingering Effects Months Later
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p4").init({"mcp":"cbs","width":"100%","height":"100%","video":"4931077","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p4","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 3, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Covid-19 Boston, MA Syndicated CBSN Boston Syndicated Local Bill Shields Coronavirus Source Type: news

Delayed bowel perforation in electrocution: an unpredictable foe - Goyal D, Dhiman A, Jagne N, Rattan A.
Electrocution injuries, particularly high voltage, are uncommon, but can be devastating. Thermal burns, arrhythmias and myonecrosis are commonly known and monitored complications of electrical injuries. Direct thermal trauma to internal viscera is also kno... (Source: SafetyLit)
Source: SafetyLit - November 28, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

AHA: Ablation Better Than Meds for Initial A-Fib Treatment
WEDNESDAY, Nov. 25, 2020 -- Cryoballoon ablation is superior to drug therapy as an initial treatment for the prevention of atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation, according to a study published online Nov. 16 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 25, 2020 Category: Pharmaceuticals Source Type: news

A more rhythmic heartbeat with calcitonin
Cardiomyocyte-released calcitonin acts on fibroblasts to limit atrial fibrosis and arrhythmia. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - November 24, 2020 Category: Science Authors: Wong, W. Tags: STKE Editors ' Choice Source Type: news

Infanticide vs. inherited cardiac arrhythmias - Brohus M, Arsov T, Wallace DA, Jensen HH, Nyegaard M, Crotti L, Adamski M, Zhang Y, Field MA, Athanasopoulos V, Bar ó I, Ribeiro de Oliveira-Mendes BB, Redon R, Charpentier F, Raju H, DiSilvestre D, Wei J, Wang R, Rafehi H, Kaspi A, Bahlo M, Dick IE, Chen SRW, Cook MC, Vinuesa CG, Overgaard MT, Schwartz PJ.
AIMS: In 2003, an Australian woman was convicted by a jury of smothering and killing her four children over a 10-year period. Each child died suddenly and unexpectedly during a sleep period, at ages ranging from 19  days to 18 months. In 2019 we were as... (Source: SafetyLit)
Source: SafetyLit - November 20, 2020 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Is Ablation Rx the Best First Choice for A-Fib?
A-fib patients who underwent ablation were half as likely to have an arrhythmia episode in the following year compared to patients on medication. And they were 61% less likely to have an episode that caused symptoms. (Source: WebMD Health)
Source: WebMD Health - November 17, 2020 Category: Consumer Health News Source Type: news

First-Line Ablation Bests Drugs for AFib in Two RCTs First-Line Ablation Bests Drugs for AFib in Two RCTs
EARLY-AF and STOP-AF First approached arrhythmia monitoring differently but both saw fewer recurrences and few serious adverse events with ablation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 17, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Is Ablation Rx the Best First Choice for A-Fib?
TUESDAY, Nov. 17, 2020 -- A procedure that freezes bits of heart tissue may be a better option than medication for people with atrial fibrillation (a-fib, or AF), two clinical trials have found. A-fib is a common heart arrhythmia in which the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 17, 2020 Category: General Medicine Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

ACC Expert Consensus on Post-TAVR Arrhythmias ACC Expert Consensus on Post-TAVR Arrhythmias
The new document was deemed essential because of the frequency, consequences, and heterogeneity of approaches to post-TAVR conduction disturbances. The pathway covers pre-, intra-, and post-TAVR.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 27, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

New-Onset Atrial Fibrillation in Sepsis: A Narrative Review
Atrial fibrillation (AF) is a frequently identified arrhythmia during the course of sepsis. The aim of this narrative review is to assess the characteristics of patients with new-onset AF related to sepsis and the risk of stroke and death, to understand if there is a need for anticoagulation. We searched for studies on AF and sepsis on PubMed, the Cochrane database, and Web of Science, and 17 studies were included. The mean incidence of new-onset AF in patients with sepsis was 20.6% (14.7% in retrospective studies and 31.6% in prospective). Risk factors for new-onset AF included advanced age, white race, male sex, obesity,...
Source: Current Awareness Service for Health (CASH) - October 9, 2020 Category: Consumer Health News Source Type: news

First Patients Treated with Galaxy Medical's Centauri(TM) Pulsed Electric Field Cardiac Ablation System
SAN CARLOS, Calif., Oct. 8, 2020 -- (Healthcare Sales & Marketing Network) -- Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients in the ECLIPSE-AF study w... Devices, Interventional, Cardiology Galaxy Medical, Pulsed Electric Field, Centauri System, cardiac ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 8, 2020 Category: Pharmaceuticals Source Type: news

Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of preCOVID19 reports
This analysis of the FAERS database found use of hydroxychloroquine and chloroquine was associated with a higher reporting rate of major CV adverse events, including cardiomyopathy (reporting OR 29.0), QT prolongation (4.5), cardiac arrhythmias (2.2) and heart failure (2.2). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 24, 2020 Category: Consumer Health News Source Type: news

Morris Animal Foundation awards nearly $1M in grants for new studies for equine health
(Morris Animal Foundation) Morris Animal Foundation, a leader in advancing animal health, has awarded nearly $1 million in large animal health research grants, supporting 14 projects. The studies will help veterinary scientists improve the well-being of horses through improved prevention and treatment of numerous health challenges, including eye cancer, heart arrhythmias and risks for injury from air transport. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 17, 2020 Category: International Medicine & Public Health Source Type: news

Medtronic TYRX(TM) Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Economic Analysis of the WRAP-IT Patient Population in Circulation: Arrhythmia and Electrophysiology Long-Term Results from WRAP-IT, Data on Impact of Infections Also Published DUBLIN, Sept. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Medt... Devices, Cardiology Medtronic, TYRX Envelope, Absorbable Antibacterial Envelope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2020 Category: Pharmaceuticals Source Type: news

Identifying, preventing and managing heart rhythm side effects of medicines
(American Heart Association) Arrhythmias are irregular heartbeats and can be caused by a variety of factors, such as genetics, heart disease, high blood pressure or electrolyte imbalances.Many commonly used medications, including over-the-counter medicines, can cause or worsen arrhythmias.Health care professionals should consider that a patient's arrhythmia may be caused or worsened by a medication. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 15, 2020 Category: International Medicine & Public Health Source Type: news

"Shot to the heart": case report and concise review of cardiac gunshot injury - Kawall T, Seecheran RV, Seecheran VK, Persad SA, Jagdeo CL, Seecheran NA.
Penetrative cardiac injury can often result in life-threatening sequelae such as myocardial contusion or rupture, coronary vessel and valvular damage, pericardial effusion with tamponade, and arrhythmias of which gunshot injury is a chief culprit. We repor... (Source: SafetyLit)
Source: SafetyLit - August 24, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

NAFLD May Predict Arrhythmia Recurrence Post-AF Ablation NAFLD May Predict Arrhythmia Recurrence Post-AF Ablation
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 14, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Antidepressant and antipsychotic poisoning - Thanacoody R.
Tricyclic antidepressants, citalopram, venlafaxine and monoamine oxidase inhibitors are the most toxic antidepressants in overdose. Features include hypotension and arrhythmias that are best managed by aggressive correction of metabolic acidosis with sodiu... (Source: SafetyLit)
Source: SafetyLit - August 13, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Alcohol Abuse Ups Mortality Risk Among Arrhythmia Patients
MONDAY, Aug. 10, 2020 -- Alcohol abuse independently increases the risk for mortality in patients with arrhythmia by more than 70 percent, according to a study presented at the American Heart Association Basic Cardiovascular Sciences 2020 Scientific... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 10, 2020 Category: Pharmaceuticals Source Type: news

Heart regeneration using stem cells: Why irregular heartbeats occur after transplantation
(Shinshu University) Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo elucidated why arrhythmia occurs post-transplant of hESC-CMs. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 5, 2020 Category: Biology Source Type: news

Cardiorespiratory Fitness Linked to Outcomes After A-Fib Ablation
MONDAY, Aug. 3, 2020 -- For patients undergoing atrial fibrillation (AF) ablation, higher cardiorespiratory fitness (CRF) is associated with reduced arrhythmia recurrence rates and death, according to a study published online Aug. 3 in Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 3, 2020 Category: Pharmaceuticals Source Type: news

Arrhythmia-free survival is indeed survival of the fittest
(Elsevier) In a new study, investigators report that patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and remaining in normal sinus rhythm. Less fit patients are rehospitalized more often, continue to use antiarrhythmic therapies longer, and have higher death rates than fitter patients. Their results appear in Heart Rhythm. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 3, 2020 Category: International Medicine & Public Health Source Type: news

Alcohol and Arrhythmia a Deadly Mix
Title: Alcohol and Arrhythmia a Deadly MixCategory: Health NewsCreated: 7/27/2020 12:00:00 AMLast Editorial Review: 7/28/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 28, 2020 Category: Cardiology Source Type: news

Alcohol abuse increases death risk after hospitalization for arrhythmia, study says
Younger adults who abuse alcohol are nearly 75% more likely to die after being hospitalized with an irregular heartbeat that those who consume healthy amounts or none at all, a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 27, 2020 Category: Consumer Health News Source Type: news

Alcohol and Arrhythmia a Deadly Mix
MONDAY, July 27, 2020 -- Alcohol abuse is associated with an increased the risk of death in people with abnormal heart rhythms, a new study warns. Researchers reviewed deaths among almost 115,000 patients aged 15-54 hospitalized for abnormal heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2020 Category: General Medicine Source Type: news

What Are Common Fatty Acid Oxidation Metabolic Disorders?
Discussion All cells and particularly their mitochondria need an energy source. Glucose is one of the most common ones, but also fatty acids, lactate, pyruvate, ketones, and amino acids. Fatty acids are formed with a carboxylic acid with a long aliphatic carbon chain usually with even numbers of carbon atoms (usually 4-28 most commonly). Most are unbranched and in foods are usually found in the form of esters. Fatty acids are important energy sources for the heart (50-70%) but also skeletal muscle where resting muscle uses both glucose and fatty acids. During fasting or increased stress fatty acids become a major source o...
Source: PediatricEducation.org - July 27, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Some Post-TAVR Arrhythmias Likely Present Pre-TAVR but Go Undetected Some Post-TAVR Arrhythmias Likely Present Pre-TAVR but Go Undetected
Prolonged pre-TAVR ECG screening in older patients with aortic stenosis reveals a high rate of arrhythmias, many of which require treatment.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 21, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Lopinavir/Ritonavir COVID-19 Treatment Linked to Bradycardia
FRIDAY, July 17, 2020 -- Lopinavir/ritonavir (LPV/RTV) treatment of COVID-19 is associated with an increased risk for bradycardia, according to a study published online July 9 in Circulation: Arrhythmia and Electrophysiology. Christophe Beyls,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 17, 2020 Category: Pharmaceuticals Source Type: news